Rozlytrek 100 mg

Rozlytrek 100 mg is a medicine authorised by Swissmedic under authorisation number 67280. The authorisation holder is Roche Pharma (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 05 November 2020 and the authorisation is limited until 20 July 2028. ATC code L01EX14 places the medicine in the group Antineoplastic agents.

Dispensing category A
Authorisation number 67280
ATC L01EX14
Synthetic medicines

Authorisation data
Authorisation number	67280
Name	Rozlytrek 100 mg
Full name	Rozlytrek 100 mg, Hartkapseln
Authorisation holder	Roche Pharma (Schweiz) AG
Medicinal product code	Synthetic medicines
Dispensing category	A · Prescription, not repeatable
ATC code	L01EX14
First authorisation	05 November 2020
Authorisation validity	20 July 2028

Strengths
No.	Name	Dispensing category	Authorisation date
1	Rozlytrek 100 mg, Hartkapseln	A	05 November 2020
2	Rozlytrek 200 mg, Hartkapseln	A	05 November 2020

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	30	Kapsel(n)	L01EX14	07.16.1.	A
2	90	Kapsel(n)	L01EX14	07.16.1.	A

Scroll the table sideways

Other medicines from this authorisation holder

Actemra 162 mg/0.9 mlAuthorisation number 63166 · ATC L04AC07A Actemra 162 mg/0.9 mlAuthorisation number 66931 · ATC L04AC07A Actemra 80 mg/4 mlAuthorisation number 58868 · ATC L04AC07A Alecensa 150 mgAuthorisation number 65970 · ATC L01ED03A Avastin 100 mg/4 mlAuthorisation number 56922 · ATC L01FG01A CellceptAuthorisation number 54701 · ATC L04AA06B Cellcept 250 mgAuthorisation number 53337 · ATC L04AA06B Cellcept 500 mgAuthorisation number 53338 · ATC L04AA06B

Frequently asked questions

Is Rozlytrek 100 mg authorised in Switzerland?

Yes. Rozlytrek 100 mg is authorised by Swissmedic under authorisation number 67280, data as of 01 September 2026. The authorisation is limited until 20 July 2028.

Which dispensing category does Rozlytrek 100 mg have?

Rozlytrek 100 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Rozlytrek 100 mg?

The authorisation holder is Roche Pharma (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.